Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance

Chaudry, Rifat A.; Cikes, Maja; Karu, Tiia; Hutchinson, Carmel; Ball, Sarah; Sutherland, George; Rosenthal, Mark; Bush, Andrew; Crowley, Suzanne
February 2011
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Feb2011, Vol. 96 Issue 2, p131
Academic Journal
Background Adults with sickle cell disease (SCD) and pulmonary hypertension have high mortality but death in SCD children with pulmonary hypertension is rare. The authors hypothesised that pulmonary hypertension in SCD children may be secondary to anaemia-induced high cardiac output rather than pulmonary vascular disease. Methods Two independent, validated techniques were used to estimate pulmonary vascular resistance (PVR) in 50 SCD children and 50 matched controls. Tricuspid regurgitant jet velocity (TRV) and right ventricular outflow tract velocity time integral were measured using Doppler echocardiography; PVR was calculated from their ratio. Acetylene rebreathing technique using respiratory mass spectrometry was also performed to calculate pulmonary blood flow and stroke index, an estimate of PVR. Results TRV was higher in SCD children compared with controls (2.28 vs 2.14 m/s, p=0.02). Fifteen of 34 (44%) children with haemoglobin of the SS genotype (HbSS) versus 1/16 (6%) children with haemoglobin of the SC genotype (HbSC) had pulmonary hypertension (TRV≥2.5 m/s) (p=0.009). Right ventricular stroke volume was higher (p<0.05) and Doppler PVR lower (1.20 (0.19) vs 1.31 (0.20) Wood units, p=0.04) in SCD children with pulmonary hypertension compared with controls. Qpeff and stroke index were higher in SCD children compared with controls (p<0.001 for both) and correlated with anaemia (p<0.001) and TRV (p=0.03). There was no correlation between TRV and history of asthma or acute chest syndrome. Conclusions Pulmonary hypertension due to raised cardiac output is common in HbSS SCD children and is associated with normal PVR. PVR should be measured before therapy with agents such as sildenafil or bosentan is contemplated.


Related Articles

  • Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 4, p120 

    The focuses on a paper which explores the impact of blood cell components on pulmonary hypertension (PH). It examines the association of hemolytic syndromes with cell-free hemoglobin (Hb) which plays a critical role in PH associated with blood diseases. Moreover, the study suggests the...

  • Treatment of Pulmonary Hypertension in Children with Chronic Lung Disease with Newer Oral Therapies. Krishnan, Usha; Krishnan, Sankaran; Gewitz, Michael // Pediatric Cardiology;Nov2008, Vol. 29 Issue 6, p1082 

    Chronic lung disease (CLD) is often complicated by chronic pulmonary vascular changes and pulmonary hypertension (PH) in young children. Current therapies for severe PH in such patients, including oxygen, inhaled nitric oxide, and parenteral prostacyclin, are often suboptimal, cumbersome, and...

  • Growth Status of Children with and without Sickle Cell Trait. Naghma-e-Rehan // Clinical Pediatrics;Nov1981, Vol. 20 Issue 11, p705 

    Because of the suggestions that children with sickle cell trait (Hb/AS) are smaller and lighter, the anthropometric measurements of 50 such children from polygamous families were compared with a matched group of 50 children with normal hemoglobin (Hb/AA) who were offsprings of the same fathers...

  • Dental considerations in the management of children suffering from sickle cell disease: A case report. Ramakrishna, Y. // Journal of the Indian Society of Pedodontics & Preventive Dentis;Sep2007, Vol. 25 Issue 3, p140 

    Sickle cell disease (SCD) is a genetically derived disorder characterized by the presence of an abnormal hemoglobin molecule, designated as hemoglobin S (HbS). It is one of the most common genetic disorder worldwide, with an estimated 70 million people carrying the sickle gene. This article...

  • Coping and health service utilisation in a UK study of paediatric sickle cell pain. Anie, K. A.; Steptoe, A.; Ball, S.; Dick, M.; Smalling, B. M. // Archives of Disease in Childhood;May2002, Vol. 86 Issue 5, p325 

    Aims: To assess sickle cell pain and coping in children and to examine the relation between these factors and the utilization of health services. Methods: Cross sectional study involving 67 children with sickle cell disease attending three London hospitals. Interviews and questionnaires involved...

  • Foreword.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 2, pIV 

    An introduction to the journal is presented in which the editor discusses the understanding, treatment, and management of pulmonary hypertension.

  • Primary Pulmonary Hypertension. Rich, Stuart; Dantzker, David R.; Ayres, Stephen M.; Bergofsky, Edward H.; Brundage, Bruce H.; Detre, Katherine M.; Fishman, Alfred P.; Goldring, Roberta M.; Groves, Bertron M.; Koerner, Spencer K.; Levy, Paul C.; Reid, Lynne M.; Vreim, Carol E.; Williams, George W. // Annals of Internal Medicine;Aug87, Vol. 107 Issue 2, p216 

    Examines baseline data from patients with primary pulmonary hypertension who have been entered in a national registry in the U.S. Recognition of pulmonary vascular disease as a primary cause of pulmonary hypertension; Demographic characteristics of the patients; Symptoms exhibited by the...

  • Pulmonary Hypertension in Children and Adolescents with Sickle Cell Disease. Onyekwere, O.; Campbell, A.; Teshome, M.; Onyeagoro, S.; Sylvan, C.; Akintilo, A.; Hutchinson, S.; Ensing, G.; Gaskin, P.; Kato, G.; Rana, S.; Kwagyan, J.; Gordeuk, V.; Williams, J.; Castro, O. // Pediatric Cardiology;Mar2008, Vol. 29 Issue 2, p309 

    The prevalence of pulmonary hypertension (PHTN) in the pediatric sickle cell disease (SCD) population is not known despite its high prevalence in adult patients. Our hypothesis was that increased pulmonary artery pressures (PAPs) would be found in SCD children and adolescents, especially those...

  • Absolute Reticulocyte Count Acts as a Surrogate for Fetal Hemoglobin in Infants and Children with Sickle Cell Anemia. Meier, Emily Riehm; Byrnes, Colleen; Weissman, Maxine; Lee, Y. Terry; Miller, Jeffery L. // PLoS ONE;9/14/2015, Vol. 10 Issue 9, p1 

    Hemoglobin switching is largely complete in humans by six months of age. Among infants with sickle cell anemia (HbSS, SCA), reticulocytosis begins early in life as fetal hemoglobin (HbF) is replaced by sickle hemoglobin (HbS). The objective of this study was to determine if absolute reticulocyte...


Read the Article


Sign out of this library

Other Topics